Kestra Medical (KMTS) analyst forecast and price target
Analyst forecast
Consensus of 8 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| JP Morgan | Initiated Coverage | Overweight | $30.00 | Aug 10, 2026 |
| Oppenheimer | Initiated Coverage | Perform | — | Jul 21, 2026 |
| BTIG | Maintained | Buy | $32.00 from $30.00 | Jul 15, 2026 |
| Goldman Sachs | Maintained | Neutral | $17.00 from $22.00 | Apr 9, 2026 |
| BTIG | Maintained | Buy | $32.00 | Apr 7, 2026 |
| BTIG | Maintained | Buy | $32.00 | Mar 25, 2026 |
| BTIG | Maintained | Buy | $32.00 | Mar 18, 2026 |
| Goldman Sachs | Maintained | Neutral | $25.00 from $22.00 | Dec 15, 2025 |
| Piper Sandler | Maintained | Overweight | $30.00 from $27.00 | Dec 12, 2025 |
| Wells Fargo | Maintained | Overweight | $28.00 from $27.00 | Dec 12, 2025 |
| BTIG | Initiated Coverage | Buy | $32.00 | Nov 18, 2025 |
| Wells Fargo | Maintained | Overweight | $27.00 from $28.00 | Jul 17, 2025 |
| Goldman Sachs | Maintained | Neutral | $23.00 from $24.00 | Apr 16, 2025 |
| Stifel | Initiated Coverage | Buy | $28.00 | Mar 31, 2025 |
| Goldman Sachs | Initiated Coverage | Neutral | $24.00 | Mar 31, 2025 |
| Wolfe Research | Initiated Coverage | Outperform | $29.00 | Mar 31, 2025 |
| Wells Fargo | Initiated Coverage | Overweight | $28.00 | Mar 31, 2025 |
Frequently asked questions
Is KMTS a buy, sell, or hold?
Analysts covering Kestra Medical currently average a Buy rating: 7 buy, 1 hold and 0 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on KMTS?
On Aug 10, 2026, JP Morgan initiated coverage of Kestra Medical at Overweight with a price target of $30.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.